Your browser doesn't support javascript.
loading
Nanoparticulates reduce tumor cell migration through affinity interactions with extracellular migrasomes and retraction fibers.
Cheng, Yuxi; Ren, Junji; Fan, Shumin; Wu, Peiyao; Cong, Wenshu; Lin, Yuxing; Lan, Shaojie; Song, Siyang; Shao, Bin; Dai, Wenbing; Wang, Xueqing; Zhang, Hua; Xu, Bo; Li, Wenzhe; Yuan, Xia; He, Bing; Zhang, Qiang.
Afiliación
  • Cheng Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Ren J; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Fan S; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Wu P; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Cong W; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Lin Y; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Lan S; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Song S; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Shao B; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Dai W; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Wang X; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Zhang H; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Xu B; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Li W; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Yuan X; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • He B; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. zqdodo@bjmu.edu.cn.
  • Zhang Q; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Nanoscale Horiz ; 7(7): 779-789, 2022 06 27.
Article en En | MEDLINE | ID: mdl-35703339
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Matriz Extracelular / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nanoscale Horiz Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Matriz Extracelular / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nanoscale Horiz Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido